University of Nottingham: Irritable Bowel Syndrome trials
The registry lists 17 Irritable Bowel Syndrome studies with University of Nottingham as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 4 3No phase 14(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Effect of Chronic Feeding of Inulin And Methylcellulose on Colonic FermentationRecruitingNCT06551961Not applicable
- Effect of Pre-dosing With Methylcellulose or Psyllium on Colonic Fermentation of InulinNot yet recruitingNCT06494137Not applicable
- Effect of MethylceIlulose or Psyllium on Fermentation of Inulin Assessed Using a Gas Sensing CapsuleCompletedNCT06551948Not applicable
- Effect of Methylcellulose or Psyllium on Fermentation of inUlin Assessed USing MRICompletedNCT06291272Not applicable
- Effect of Modified Cellulose on Colonic Fermentation of InulinCompletedNCT05911347Not applicable
- Effect of Rate Of Delivery on Colonic Fermentation of inuliN (EON)CompletedNCT05619341Not applicable
- Carbohydrate Reduction and Impact on Gastrointestinal SystemCompletedNCT03729622Not applicable
- Fibre and Gas in Irritable Bowel SyndromeCompletedNCT03265002Not applicable
- Reclassifying Constipation Using Imaging and ManometryStatus unknownNCT03226145Not applicable
- The Effect of the Low FODMAP Diet and Dietary Oligofructose on Gastrointestinal Form, Function and MicrobiotaCompletedNCT02259465Not applicable
- Campylobacter Enteritis and Post-Infective Bowel Dysfunction (PI-BD): Role of Antibiotics and MicrobiotaStatus unknownNCT02040922
- Fructose and Fructans in Irritabla Bowel SyndromeCompletedNCT01776853Not applicable
- Mode of Action of MoviprepCompletedNCT01622972Phase 4
- Small and Large Bowel Transit Tests Using MRI (Study 1)CompletedNCT01534507
- Mesalazine for the Treatment of Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D)CompletedNCT01316718Phase 4
- Saccharomyces Cerevisiae CNCM I-3856 Treatment in Irritable Bowel Syndrome With Diarrhea (IBS-D) and Post Infective Bowel DysfunctionWithdrawnNCT00977587Not applicable
- Ondansetron for the Treatment of IBS With Diarrhoea (IBS-D)CompletedNCT00745004Phase 4